{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T08:32:46Z","timestamp":1777710766716,"version":"3.51.4"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Domp\u00e8 Farmaceutici , Italy"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"DOI":"10.1186\/s10194-024-01890-4","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T08:02:14Z","timestamp":1729843334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Intranasal administration of recombinant human BDNF as a potential therapy for some primary headaches"],"prefix":"10.1186","volume":"25","author":[{"given":"Rosaria","family":"Greco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Francavilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Facchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Demartini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Zanaboni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Irene","family":"Antonangeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Maffei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franca","family":"Cattani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Aramini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Allegretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Tassorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidia","family":"De Filippis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,25]]},"reference":[{"key":"1890_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.ncl.2019.06.001","volume":"37","author":"RC Burch","year":"2019","unstructured":"Burch RC, Buse DC, Lipton RB (2019) Migraine Neurol Clin 37:631\u2013649. https:\/\/doi.org\/10.1016\/j.ncl.2019.06.001","journal-title":"Migraine Neurol Clin"},{"key":"1890_CR2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"GBD 2021 Nervous System Disorders Collaborators","year":"2024","unstructured":"GBD 2021 Nervous System Disorders Collaborators (2024) Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the global burden of Disease Study 2021. Lancet Neurol 23:344\u2013381. https:\/\/doi.org\/10.1016\/S1474-4422(24)00038-3","journal-title":"Lancet Neurol"},{"key":"1890_CR3","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2165\/11534920-000000000-00000","volume":"24","author":"PL Durham","year":"2010","unstructured":"Durham PL, Vause CV (2010) Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine. CNS Drugs 24:539\u2013548. https:\/\/doi.org\/10.2165\/11534920-000000000-00000","journal-title":"CNS Drugs"},{"key":"1890_CR4","doi-asserted-by":"publisher","first-page":"831035","DOI":"10.3389\/fneur.2021.831035","volume":"12","author":"A M\u00ednguez-Olaondo","year":"2021","unstructured":"M\u00ednguez-Olaondo A, Quintas S, Moroll\u00f3n S\u00e1nchez-Mateos N et al (2021) Cutaneous Allodynia in Migraine: a narrative review. Front Neurol 12:831035. https:\/\/doi.org\/10.3389\/fneur.2021.831035","journal-title":"Front Neurol"},{"key":"1890_CR5","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1007\/s10072-024-07372-4","volume":"45","author":"M Deodato","year":"2024","unstructured":"Deodato M, Granato A, Martini M et al (2024) Instrumental assessment of pressure pain threshold over trigeminal and extra-trigeminal area in people with episodic and chronic migraine: a cross-sectional observational study. Neurol Sci 45:3923\u20133929. https:\/\/doi.org\/10.1007\/s10072-024-07372-4","journal-title":"Neurol Sci"},{"key":"1890_CR6","doi-asserted-by":"publisher","unstructured":"Aguggia M, Saracco MG (2010) Pathophysiology of migraine chronification. Neurol Sci 31(Suppl 1). https:\/\/doi.org\/10.1007\/s10072-010-0264-y. :S15-7","DOI":"10.1007\/s10072-010-0264-y"},{"key":"1890_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11916-001-0013-2","volume":"5","author":"L Edvinsson","year":"2001","unstructured":"Edvinsson L (2001) Pathophysiology of primary headaches. Curr Pain Headache Rep 5:71\u201378. https:\/\/doi.org\/10.1007\/s11916-001-0013-2","journal-title":"Curr Pain Headache Rep"},{"key":"1890_CR8","doi-asserted-by":"publisher","first-page":"e14786","DOI":"10.1016\/j.heliyon.2023.e14786","volume":"9","author":"Z Wang","year":"2023","unstructured":"Wang Z, Yang X, Zhao B, Li W (2023) Primary headache disorders: from pathophysiology to neurostimulation therapies. Heliyon 9:e14786. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e14786","journal-title":"Heliyon"},{"key":"1890_CR9","doi-asserted-by":"publisher","unstructured":"Dodick DW (2018) A phase-by-phase review of Migraine Pathophysiology. Headache 58 Suppl 14\u201316. https:\/\/doi.org\/10.1111\/head.13300","DOI":"10.1111\/head.13300"},{"key":"1890_CR10","doi-asserted-by":"publisher","first-page":"18006","DOI":"10.1038\/nrdp.2018.6","volume":"4","author":"A May","year":"2018","unstructured":"May A, Schwedt TJ, Magis D et al (2018) Cluster headache. Nat Rev Dis Primers 4:18006. https:\/\/doi.org\/10.1038\/nrdp.2018.6","journal-title":"Nat Rev Dis Primers"},{"key":"1890_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s10194-019-1066-0","volume":"20","author":"AP Andreou","year":"2019","unstructured":"Andreou AP, Edvinsson L (2019) Mechanisms of migraine as a chronic evolutive condition. J Headache Pain 20:117. https:\/\/doi.org\/10.1186\/s10194-019-1066-0","journal-title":"J Headache Pain"},{"key":"1890_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/jemt.1081","volume":"53","author":"DJ Williamson","year":"2001","unstructured":"Williamson DJ, Hargreaves RJ (2001) Neurogenic inflammation in the context of migraine. Microsc Res Tech 53:167\u2013178. https:\/\/doi.org\/10.1002\/jemt.1081","journal-title":"Microsc Res Tech"},{"key":"1890_CR13","first-page":"S16","volume":"43","author":"MA Moskowitz","year":"1993","unstructured":"Moskowitz MA (1993) Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 43:S16\u201320","journal-title":"Neurology"},{"key":"1890_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s10194-018-0852-4","volume":"19","author":"L Edvinsson","year":"2018","unstructured":"Edvinsson L, Tajti J, Szal\u00e1rdy L, V\u00e9csei L (2018) PACAP and its role in primary headaches. J Headache Pain 19:21. https:\/\/doi.org\/10.1186\/s10194-018-0852-4","journal-title":"J Headache Pain"},{"key":"1890_CR15","doi-asserted-by":"crossref","unstructured":"Seybold VS (2009) The Role of Peptides in Central Sensitization. pp 451\u2013491","DOI":"10.1007\/978-3-540-79090-7_13"},{"key":"1890_CR16","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/384560a0","volume":"384","author":"AM Strassman","year":"1996","unstructured":"Strassman AM, Raymond SA, Burstein R (1996) Sensitization of meningeal sensory neurons and the origin of headaches. Nature 384:560\u2013564. https:\/\/doi.org\/10.1038\/384560a0","journal-title":"Nature"},{"key":"1890_CR17","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/head.13529","volume":"59","author":"S Iyengar","year":"2019","unstructured":"Iyengar S, Johnson KW, Ossipov MH, Aurora SK (2019) CGRP and the Trigeminal System in Migraine. Headache: J Head Face Pain 59:659\u2013681. https:\/\/doi.org\/10.1111\/head.13529","journal-title":"Headache: J Head Face Pain"},{"key":"1890_CR18","doi-asserted-by":"crossref","unstructured":"Caronna E, Alpuente A, Torres-Ferrus M, Pozo-Rosich P (2024) CGRP monoclonal antibodies and CGRP receptor antagonists (Gepants) in migraine prevention. pp 107\u2013124","DOI":"10.1016\/B978-0-12-823357-3.00024-0"},{"key":"1890_CR19","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.3390\/cells12222649","volume":"12","author":"M Tanaka","year":"2023","unstructured":"Tanaka M, Szab\u00f3 \u00c1, K\u00f6rt\u00e9si T et al (2023) From CGRP to PACAP, VIP, and Beyond: unraveling the Next chapters in Migraine Treatment. Cells 12:2649. https:\/\/doi.org\/10.3390\/cells12222649","journal-title":"Cells"},{"key":"1890_CR20","doi-asserted-by":"publisher","first-page":"e2118543","DOI":"10.1001\/jamanetworkopen.2021.18543","volume":"4","author":"L Pellesi","year":"2021","unstructured":"Pellesi L, Al-Karagholi MA-M, De Icco R et al (2021) Effect of Vasoactive Intestinal Polypeptide on Development of Migraine headaches. JAMA Netw Open 4:e2118543. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.18543","journal-title":"JAMA Netw Open"},{"key":"1890_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s10194-023-01569-2","volume":"24","author":"A Kuburas","year":"2023","unstructured":"Kuburas A, Russo AF (2023) Shared and independent roles of CGRP and PACAP in migraine pathophysiology. J Headache Pain 24:34. https:\/\/doi.org\/10.1186\/s10194-023-01569-2","journal-title":"J Headache Pain"},{"key":"1890_CR22","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1096\/fj.11-203042","volume":"26","author":"AC Emery","year":"2012","unstructured":"Emery AC, Eiden LE (2012) Signaling through the neuropeptide GPCR PAC 1 induces neuritogenesis via a single linear cAMP- and ERK\u2010dependent pathway using a novel cAMP sensor. FASEB J 26:3199\u20133211. https:\/\/doi.org\/10.1096\/fj.11-203042","journal-title":"FASEB J"},{"key":"1890_CR23","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1177\/0333102420949173","volume":"40","author":"BN Mason","year":"2020","unstructured":"Mason BN, Wattiez A-S, Balcziak LK et al (2020) Vascular actions of peripheral CGRP in migraine-like photophobia in mice. Cephalalgia 40:1585\u20131604. https:\/\/doi.org\/10.1177\/0333102420949173","journal-title":"Cephalalgia"},{"key":"1890_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s10194-019-0968-1","volume":"20","author":"F De Logu","year":"2019","unstructured":"De Logu F, Landini L, Janal MN et al (2019) Migraine-provoking substances evoke periorbital allodynia in mice. J Headache Pain 20:18. https:\/\/doi.org\/10.1186\/s10194-019-0968-1","journal-title":"J Headache Pain"},{"key":"1890_CR25","doi-asserted-by":"publisher","unstructured":"Pellesi L, Al-Karagholi MA-M, De Icco R et al (2022) Plasma levels of CGRP during a 2-h infusion of VIP in healthy volunteers and patients with migraine: an exploratory study. Front Neurol 13. https:\/\/doi.org\/10.3389\/fneur.2022.871176","DOI":"10.3389\/fneur.2022.871176"},{"key":"1890_CR26","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1177\/0333102420937655","volume":"40","author":"L Pellesi","year":"2020","unstructured":"Pellesi L, Al-Karagholi MA-M, Chaudhry BA et al (2020) Two-hour infusion of vasoactive intestinal polypeptide induces delayed headache and extracranial vasodilation in healthy volunteers. Cephalalgia 40:1212\u20131223. https:\/\/doi.org\/10.1177\/0333102420937655","journal-title":"Cephalalgia"},{"key":"1890_CR27","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1046\/j.1523-1747.2001.01306.x","volume":"116","author":"M Kakurai","year":"2001","unstructured":"Kakurai M, Murata S, Nakagawa H et al (2001) Vasoactive intestinal peptide regulates its receptor expression and functions of human keratinocytes via type I vasoactive intestinal peptide receptors. J Invest Dermatology 116:743\u2013749. https:\/\/doi.org\/10.1046\/j.1523-1747.2001.01306.x","journal-title":"J Invest Dermatology"},{"key":"1890_CR28","first-page":"28","volume":"3","author":"A Malick","year":"2000","unstructured":"Malick A, Burstein R (2000) Peripheral and central sensitization during migraine. Funct Neurol 15 Suppl 3:28\u201335","journal-title":"Funct Neurol 15 Suppl"},{"key":"1890_CR29","doi-asserted-by":"publisher","unstructured":"Sances G, Tassorelli C, Pucci E et al (2004) Reliability of the nitroglycerin provocative test in the diagnosis of neurovascular headaches. https:\/\/doi.org\/10.1111\/j.1468-2982.2004.00639.x. Cephalalgia","DOI":"10.1111\/j.1468-2982.2004.00639.x"},{"key":"1890_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.pneurobio.2019.02.002","volume":"177","author":"C Demartini","year":"2019","unstructured":"Demartini C, Greco R, Zanaboni AM et al (2019) Nitroglycerin as a comparative experimental model of migraine pain: from animal to human and back. Prog Neurobiol 177:15\u201332. https:\/\/doi.org\/10.1016\/j.pneurobio.2019.02.002","journal-title":"Prog Neurobiol"},{"key":"1890_CR31","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/brain\/120.2.283","volume":"120","author":"M Fanciullacci","year":"1997","unstructured":"Fanciullacci M (1997) Responsiveness of the trigeminovascular system to nitroglycerine in cluster headache patients. Brain 120:283\u2013288. https:\/\/doi.org\/10.1093\/brain\/120.2.283","journal-title":"Brain"},{"key":"1890_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/brain\/awy313","volume":"142","author":"S Akerman","year":"2019","unstructured":"Akerman S, Karsan N, Bose P et al (2019) Nitroglycerine triggers triptan-responsive cranial allodynia and trigeminal neuronal hypersensitivity. Brain 142:103\u2013119. https:\/\/doi.org\/10.1093\/brain\/awy313","journal-title":"Brain"},{"key":"1890_CR33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1468-2982.2005.00836.x","volume":"25","author":"G Juhasz","year":"2005","unstructured":"Juhasz G, Zsombok T, Jakab B et al (2005) Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack. Cephalalgia 25:179\u2013183. https:\/\/doi.org\/10.1111\/j.1468-2982.2005.00836.x","journal-title":"Cephalalgia"},{"key":"1890_CR34","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1134\/S1819712412030129","volume":"6","author":"TA Sakharnova","year":"2012","unstructured":"Sakharnova TA, Vedunova MV, Mukhina IV (2012) Brain-derived neurotrophic factor (BDNF) and its role in the functioning of the central nervous system. Neurochemical J 6:251\u2013259. https:\/\/doi.org\/10.1134\/S1819712412030129","journal-title":"Neurochemical J"},{"key":"1890_CR35","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neuropharm.2015.10.034","volume":"102","author":"C Bj\u00f6rkholm","year":"2016","unstructured":"Bj\u00f6rkholm C, Monteggia LM (2016) BDNF \u2013 a key transducer of antidepressant effects. Neuropharmacology 102:72\u201379. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.10.034","journal-title":"Neuropharmacology"},{"key":"1890_CR36","doi-asserted-by":"crossref","unstructured":"Latremoliere A, Woolf CJ (2009) Central Sensitization: a generator of Pain Hypersensitivity by Central neural plasticity. Journal of Pain","DOI":"10.1016\/j.jpain.2009.06.012"},{"key":"1890_CR37","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1177\/0333102410368443","volume":"30","author":"C Lemos","year":"2010","unstructured":"Lemos C, Mendon\u00e7a D, Pereira-Monteiro J et al (2010) BDNF and CGRP interaction: implications in migraine susceptibility. Cephalalgia 30:1375\u20131382. https:\/\/doi.org\/10.1177\/0333102410368443","journal-title":"Cephalalgia"},{"key":"1890_CR38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.aanat.2015.12.001","volume":"207","author":"C Salio","year":"2016","unstructured":"Salio C, Ferrini F (2016) BDNF and GDNF expression in discrete populations of nociceptors. Annals Anat - Anatomischer Anzeiger 207:55\u201361. https:\/\/doi.org\/10.1016\/j.aanat.2015.12.001","journal-title":"Annals Anat - Anatomischer Anzeiger"},{"key":"1890_CR39","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s10194-012-0454-5","volume":"13","author":"M Fischer","year":"2012","unstructured":"Fischer M, Wille G, Klien S et al (2012) Brain-derived neurotrophic factor in primary headaches. J Headache Pain 13:469\u2013475. https:\/\/doi.org\/10.1007\/s10194-012-0454-5","journal-title":"J Headache Pain"},{"key":"1890_CR40","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1468-2982.2005.01006.x","volume":"26","author":"F Blandini","year":"2006","unstructured":"Blandini F, Rinaldi L, Tassorelli C et al (2006) Peripheral levels of BDNF and NGF in primary headaches. Cephalalgia 26:136\u2013142. https:\/\/doi.org\/10.1111\/j.1468-2982.2005.01006.x","journal-title":"Cephalalgia"},{"key":"1890_CR41","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/sj.gt.3301814","volume":"9","author":"MJ Eaton","year":"2002","unstructured":"Eaton MJ, Blits B, Ruitenberg MJ et al (2002) Amelioration of chronic neuropathic pain after partial nerve injury by adeno-associated viral (AAV) vector-mediated over-expression of BDNF in the rat spinal cord. Gene Ther 9:1387\u20131395. https:\/\/doi.org\/10.1038\/sj.gt.3301814","journal-title":"Gene Ther"},{"key":"1890_CR42","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0304-3940(99)00908-8","volume":"278","author":"K Miki","year":"2000","unstructured":"Miki K, Fukuoka T, Tokunaga A et al (2000) Differential effect of brain-derived neurotrophic factor on high-threshold mechanosensitivity in a rat neuropathic pain model. Neurosci Lett 278:85\u201388. https:\/\/doi.org\/10.1016\/S0304-3940(99)00908-8","journal-title":"Neurosci Lett"},{"key":"1890_CR43","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.neuroscience.2010.03.002","volume":"167","author":"L Tarsa","year":"2010","unstructured":"Tarsa L, Ba\u0142kowiec-Iskra E, Kratochvil FJ et al (2010) Tooth pulp inflammation increases brain-derived neurotrophic factor expression in rodent trigeminal ganglion neurons. Neuroscience 167:1205\u20131215. https:\/\/doi.org\/10.1016\/j.neuroscience.2010.03.002","journal-title":"Neuroscience"},{"key":"1890_CR44","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1080\/01616412.2021.1922181","volume":"43","author":"V Koute","year":"2021","unstructured":"Koute V, Michalopoulou A, Siokas V et al (2021) Val66Met polymorphism is associated with decreased likelihood for pediatric headache and migraine. Neurol Res 43:715\u2013723. https:\/\/doi.org\/10.1080\/01616412.2021.1922181","journal-title":"Neurol Res"},{"key":"1890_CR45","doi-asserted-by":"publisher","unstructured":"Terrazzino S, Cargnin S, Viana M et al (2017) Brain-derived neurotrophic factor Val66Met gene polymorphism impacts on Migraine susceptibility: a Meta-analysis of case\u2013control studies. https:\/\/doi.org\/10.3389\/fneur.2017.00159. Front Neurol 8:","DOI":"10.3389\/fneur.2017.00159"},{"key":"1890_CR46","doi-asserted-by":"crossref","unstructured":"Tassorelli C, Joseph SA, Buzzi MG, Nappi G (1999) The effects on the central nervous system of nitroglycerin - putative mechanisms and mediators. Prog Neurobiol","DOI":"10.1016\/S0301-0082(98)00071-9"},{"key":"1890_CR47","doi-asserted-by":"publisher","first-page":"104624","DOI":"10.1016\/j.nbd.2019.104624","volume":"134","author":"R Greco","year":"2020","unstructured":"Greco R, Demartini C, Zanaboni AM et al (2020) FAAH inhibition as a preventive treatment for migraine: a pre-clinical study. Neurobiol Dis 134:104624. https:\/\/doi.org\/10.1016\/j.nbd.2019.104624","journal-title":"Neurobiol Dis"},{"key":"1890_CR48","doi-asserted-by":"publisher","unstructured":"Greco R, Demartini C, Zanaboni A et al (2021) Characterization of the peripheral FAAH inhibitor, URB937, in animal models of acute and chronic migraine. Neurobiol Dis 147. https:\/\/doi.org\/10.1016\/j.nbd.2020.105157","DOI":"10.1016\/j.nbd.2020.105157"},{"key":"1890_CR49","doi-asserted-by":"publisher","unstructured":"Greco R, Demartini C, Francavilla M et al (2022) Antagonism of CGRP receptor: Central and Peripheral mechanisms and mediators in an animal model of chronic migraine. https:\/\/doi.org\/10.3390\/cells11193092. Cells 11:","DOI":"10.3390\/cells11193092"},{"key":"1890_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-016-0624-y","author":"KJ Sufka","year":"2016","unstructured":"Sufka KJ, Staszko SM, Johnson AP et al (2016) Clinically relevant behavioral endpoints in a recurrent nitroglycerin migraine model in rats. J Headache Pain. https:\/\/doi.org\/10.1186\/s10194-016-0624-y","journal-title":"J Headache Pain"},{"key":"1890_CR51","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/ejn.13486","volume":"45","author":"F Farajdokht","year":"2017","unstructured":"Farajdokht F, Babri S, Karimi P et al (2017) Chronic ghrelin treatment reduced photophobia and anxiety-like behaviors in nitroglycerin\u2010 induced migraine: role of pituitary adenylate cyclase\u2010activating polypeptide. Eur J Neurosci 45:763\u2013772. https:\/\/doi.org\/10.1111\/ejn.13486","journal-title":"Eur J Neurosci"},{"key":"1890_CR52","doi-asserted-by":"publisher","unstructured":"Bates EA, Nikai T, Brennan KC et al (2010) Sumatriptan alleviates nitroglycerin-induced mechanical and thermal allodynia in mice. https:\/\/doi.org\/10.1111\/j.1468-2982.2009.01864.x. Cephalalgia","DOI":"10.1111\/j.1468-2982.2009.01864.x"},{"key":"1890_CR53","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1006\/exnr.2000.7521","volume":"167","author":"S Bingham","year":"2001","unstructured":"Bingham S, Davey PT, Sammons M et al (2001) Inhibition of inflammation-induced thermal hypersensitivity by sumatriptan through activation of 5-HT1B\/1D receptors. Exp Neurol 167:65\u201373. https:\/\/doi.org\/10.1006\/exnr.2000.7521","journal-title":"Exp Neurol"},{"key":"1890_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01736-1","author":"G Casili","year":"2020","unstructured":"Casili G, Lanza M, Filippone A et al (2020) Dimethyl fumarate alleviates the nitroglycerin (NTG)-induced migraine in mice. J Neuroinflammation. https:\/\/doi.org\/10.1186\/s12974-020-01736-1","journal-title":"J Neuroinflammation"},{"key":"1890_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1993.tb13643.x","author":"H Kaube","year":"1993","unstructured":"Kaube H, Hoskin KL, Goadsby PJ (1993) Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption. Br J Pharmacol. https:\/\/doi.org\/10.1111\/j.1476-5381.1993.tb13643.x","journal-title":"Br J Pharmacol"},{"key":"1890_CR56","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.pain.2013.10.004","volume":"155","author":"AA Pradhan","year":"2014","unstructured":"Pradhan AA, Smith ML, McGuire B et al (2014) Characterization of a novel model of chronic migraine. Pain 155:269\u2013274. https:\/\/doi.org\/10.1016\/j.pain.2013.10.004","journal-title":"Pain"},{"key":"1890_CR57","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1177\/0333102415623070","volume":"36","author":"AF Tipton","year":"2016","unstructured":"Tipton AF, Tarash I, McGuire B et al (2016) The effects of acute and preventive migraine therapies in a mouse model of chronic migraine. Cephalalgia 36:1048\u20131056. https:\/\/doi.org\/10.1177\/0333102415623070","journal-title":"Cephalalgia"},{"key":"1890_CR58","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/0333102418777507","volume":"39","author":"LS Moye","year":"2019","unstructured":"Moye LS, Novack ML, Tipton AF et al (2019) The development of a mouse model of mTBI-induced post-traumatic migraine, and identification of the delta opioid receptor as a novel therapeutic target. Cephalalgia 39:77\u201390. https:\/\/doi.org\/10.1177\/0333102418777507","journal-title":"Cephalalgia"},{"key":"1890_CR59","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1016\/j.pain.2013.07.021","volume":"154","author":"R Noseda","year":"2013","unstructured":"Noseda R, Burstein R (2013) Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain. Pain 154:S44\u2013S53. https:\/\/doi.org\/10.1016\/j.pain.2013.07.021","journal-title":"Pain"},{"key":"1890_CR60","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.neubiorev.2003.12.003","volume":"28","author":"P Raboisson","year":"2004","unstructured":"Raboisson P, Dallel R (2004) The orofacial formalin test. Neurosci Biobehav Rev 28:219\u2013226. https:\/\/doi.org\/10.1016\/j.neubiorev.2003.12.003","journal-title":"Neurosci Biobehav Rev"},{"key":"1890_CR61","unstructured":"Ghelardini C, Galeotti N, Figini M et al (1996) The central cholinergic system has a role in the antinociception induced in rodents and guinea pigs by the antimigraine drug sumatriptan. Journal of Pharmacology and Experimental Therapeutics"},{"key":"1890_CR62","doi-asserted-by":"publisher","unstructured":"Huang D, Ren L, Qiu CS et al (2016) Characterization of a mouse model of headache. https:\/\/doi.org\/10.1097\/j.pain.0000000000000578. Pain","DOI":"10.1097\/j.pain.0000000000000578"},{"key":"1890_CR63","doi-asserted-by":"publisher","unstructured":"Knyih\u00e1r-Csillik E, Tajti J, Samsara M et al (1997) Effect of a serotonin agonist (sumatriptan) on the peptidergic innervation of the rat cerebral dura mater and on the expression of c-fos in the caudal trigeminal nucleus in an experimental migraine model. J Neurosci Res. https:\/\/doi.org\/10.1002\/(SICI)1097-4547(19970601)48:5%3C;449::AID-JNR6%3E;3.3.CO;2-X","DOI":"10.1002\/(SICI)1097-4547(19970601)48:5%3C;449::AID-JNR6%3E;3.3.CO;2-X"},{"key":"1890_CR64","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000000640","author":"MA Tomi\u0107","year":"2015","unstructured":"Tomi\u0107 MA, Pecikoza UB, Micov AM et al (2015) The effects of levetiracetam, sumatriptan, and caffeine in a rat model of trigeminal pain: interactions in 2-component combinations. Anesth Analg. https:\/\/doi.org\/10.1213\/ANE.0000000000000640","journal-title":"Anesth Analg"},{"key":"1890_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116670","author":"E Mohammadi Vosough","year":"2019","unstructured":"Mohammadi Vosough E, Baradaran Rahimi V, Masoud SA et al (2019) Evaluation of protective effects of non-selective cannabinoid receptor agonist WIN 55,212-2 against the nitroglycerine-induced acute and chronic animal models of migraine: a mechanistic study. Life Sci. https:\/\/doi.org\/10.1016\/j.lfs.2019.116670","journal-title":"Life Sci"},{"key":"1890_CR66","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s10194-018-0879-6","volume":"19","author":"R Greco","year":"2018","unstructured":"Greco R, Demartini C, Zanaboni AM, Tassorelli C (2018) Chronic and intermittent administration of systemic nitroglycerin in the rat induces an increase in the gene expression of CGRP in central areas: potential contribution to pain processing. J Headache Pain 19:51. https:\/\/doi.org\/10.1186\/s10194-018-0879-6","journal-title":"J Headache Pain"},{"key":"1890_CR67","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.lfs.2018.01.030","volume":"197","author":"H Tateiwa","year":"2018","unstructured":"Tateiwa H, Kawano T, Nishigaki A et al (2018) The role of hippocampal brain-derived neurotrophic factor in age-related differences in neuropathic pain behavior in rats. Life Sci 197:56\u201366. https:\/\/doi.org\/10.1016\/j.lfs.2018.01.030","journal-title":"Life Sci"},{"key":"1890_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2017.05.012","author":"JKS Krishnan","year":"2017","unstructured":"Krishnan JKS, Arun P, Chembukave B et al (2017) Effect of administration method, animal weight and age on the intranasal delivery of drugs to the brain. J Neurosci Methods. https:\/\/doi.org\/10.1016\/j.jneumeth.2017.05.012","journal-title":"J Neurosci Methods"},{"key":"1890_CR69","doi-asserted-by":"crossref","unstructured":"Manni L, Conti G, Chiaretti A, Soligo M (2021) Intranasal delivery of nerve growth factor in neurodegenerative diseases and Neurotrauma. Front Pharmacol","DOI":"10.3389\/fphar.2021.754502"},{"key":"1890_CR70","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3109\/10611860903318134","volume":"18","author":"SR Alcal\u00e1-Barraza","year":"2010","unstructured":"Alcal\u00e1-Barraza SR, Lee MS, Hanson LR et al (2010) Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS. J Drug Target 18:179\u2013190. https:\/\/doi.org\/10.3109\/10611860903318134","journal-title":"J Drug Target"},{"key":"1890_CR71","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1177\/0333102416678000","volume":"37","author":"R Greco","year":"2017","unstructured":"Greco R, Demartini C, Zanaboni AM et al (2017) Effects of kynurenic acid analogue 1 (KYNA-A1) in nitroglycerin-induced hyperalgesia: targets and anti-migraine mechanisms. Cephalalgia 37:1272\u20131284. https:\/\/doi.org\/10.1177\/0333102416678000","journal-title":"Cephalalgia"},{"key":"1890_CR72","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/bs.vh.2016.10.003","volume":"104","author":"LB Martins","year":"2017","unstructured":"Martins LB, Teixeira AL, Domingues RB (2017) Neurotrophins and migraine. Vitam Horm 104:459\u2013473. https:\/\/doi.org\/10.1016\/bs.vh.2016.10.003","journal-title":"Vitam Horm"},{"key":"1890_CR73","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2006.04161.x","author":"I Buldyrev","year":"2006","unstructured":"Buldyrev I, Tanner NM, Hsieh HY et al (2006) Calcitonin gene-related peptide enhances release of native brain-derived neurotrophic factor from trigeminal ganglion neurons. J Neurochem. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.04161.x","journal-title":"J Neurochem"},{"key":"1890_CR74","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s10194-023-01603-3","volume":"24","author":"L Zhang","year":"2023","unstructured":"Zhang L, Zhou Y, Yang L et al (2023) PACAP6-38 improves nitroglycerin-induced central sensitization by modulating synaptic plasticity at the trigeminal nucleus caudalis in a male rat model of chronic migraine. J Headache Pain 24:66. https:\/\/doi.org\/10.1186\/s10194-023-01603-3","journal-title":"J Headache Pain"},{"key":"1890_CR75","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1111\/head.14635","volume":"63","author":"AI Scher","year":"2023","unstructured":"Scher AI, McGinley JS, VanDam LR et al (2023) Plasma calcitonin gene-related peptide and nerve growth factor as headache and pain biomarkers in recently deployed soldiers with and without a recent concussion. Headache 63:1240\u20131250. https:\/\/doi.org\/10.1111\/head.14635","journal-title":"Headache"},{"key":"1890_CR76","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/head.14625","volume":"63","author":"M Fila","year":"2023","unstructured":"Fila M, Pawlowska E, Szczepanska J, Blasiak J (2023) Autophagy may protect the brain against prolonged consequences of headache attacks: a narrative\/hypothesis review. Headache 63:1154\u20131166. https:\/\/doi.org\/10.1111\/head.14625","journal-title":"Headache"},{"key":"1890_CR77","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/bph.16242","volume":"181","author":"S Akerman","year":"2024","unstructured":"Akerman S, Goadsby PJ, Romero-Reyes M (2024) PACAP-38 related modulation of the cranial parasympathetic projection: a novel mechanism and therapeutic target in severe primary headache. Br J Pharmacol 181:480\u2013494. https:\/\/doi.org\/10.1111\/bph.16242","journal-title":"Br J Pharmacol"},{"key":"1890_CR78","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1177\/0333102413483929","volume":"33","author":"L Edvinsson","year":"2013","unstructured":"Edvinsson L (2013) Role of VIP\/PACAP in primary headachestle. Cephalalgia 33:1070\u20131072. https:\/\/doi.org\/10.1177\/0333102413483929","journal-title":"Cephalalgia"},{"key":"1890_CR79","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.3390\/cells11111768","volume":"11","author":"M Dux","year":"2022","unstructured":"Dux M, Vogler B, Kuhn A et al (2022) The Anti-CGRP antibody Fremanezumab lowers CGRP release from Rat Dura Mater and Meningeal Blood Flow. Cells 11:1768. https:\/\/doi.org\/10.3390\/cells11111768","journal-title":"Cells"},{"key":"1890_CR80","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3390\/cells12010143","volume":"12","author":"AR Pavelic","year":"2022","unstructured":"Pavelic AR, W\u00f6ber C, Riederer F, Zebenholzer K (2022) Monoclonal antibodies against calcitonin gene-related peptide for Migraine Prophylaxis: a systematic review of real-World Data. Cells 12:143. https:\/\/doi.org\/10.3390\/cells12010143","journal-title":"Cells"},{"key":"1890_CR81","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.3390\/cells11233795","volume":"11","author":"T K\u00f6rt\u00e9si","year":"2022","unstructured":"K\u00f6rt\u00e9si T, Spekker E, V\u00e9csei L (2022) Exploring the Tryptophan Metabolic pathways in Migraine-related mechanisms. Cells 11:3795. https:\/\/doi.org\/10.3390\/cells11233795","journal-title":"Cells"},{"key":"1890_CR82","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1046\/j.1468-2982.1990.1001039.x","volume":"10","author":"M Nicolodi","year":"1990","unstructured":"Nicolodi M, Bianco E Del (1990) Sensory neuropeptides (substance P, calcitonin gene-related peptide) and vasoactive intestinal polypeptide in human saliva: their pattern in Migraine and Cluster Headache. Cephalalgia 10:39\u201350. https:\/\/doi.org\/10.1046\/j.1468-2982.1990.1001039.x","journal-title":"Cephalalgia"},{"key":"1890_CR83","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.3390\/ijms25073706","volume":"25","author":"S Park","year":"2024","unstructured":"Park S, Jung H, Han S-W et al (2024) Differences in Neuropathology between Nitroglycerin-Induced mouse models of episodic and chronic migraine. Int J Mol Sci 25:3706. https:\/\/doi.org\/10.3390\/ijms25073706","journal-title":"Int J Mol Sci"},{"key":"1890_CR84","doi-asserted-by":"publisher","unstructured":"Bon I E (2022) Trigeminal Sensor System of the rat, Development and Morphofunctional features. Biomed J Sci Tech Res 44. https:\/\/doi.org\/10.26717\/BJSTR.2022.44.007091","DOI":"10.26717\/BJSTR.2022.44.007091"},{"key":"1890_CR85","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0006-8993(80)90263-2","volume":"186","author":"KB Sims","year":"1980","unstructured":"Sims KB, Hoffman DL, Said SI, Zimmerman EA (1980) Vasoactive intestinal polypeptide (VIP) in mouse and rat brain: an immunocytochemical study. Brain Res 186:165\u2013183. https:\/\/doi.org\/10.1016\/0006-8993(80)90263-2","journal-title":"Brain Res"},{"key":"1890_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(95)00348-T","author":"C Tassorelli","year":"1995","unstructured":"Tassorelli C, Joseph SA (1995) Systemic nitroglycerin induces Fos immunoreactivity in brainstem and forebrain structures of the rat. Brain Res. https:\/\/doi.org\/10.1016\/0006-8993(95)00348-T","journal-title":"Brain Res"},{"key":"1890_CR87","first-page":"230","volume":"1","author":"R Uddman","year":"1989","unstructured":"Uddman R, Edvinsson L (1989) Neuropeptides in the cerebral circulation. Cerebrovasc Brain Metab Rev 1:230\u2013252","journal-title":"Cerebrovasc Brain Metab Rev"},{"key":"1890_CR88","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.npep.2014.01.004","volume":"48","author":"I Jansen-Olesen","year":"2014","unstructured":"Jansen-Olesen I, Baun M, Amrutkar DV et al (2014) PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor. Neuropeptides 48:53\u201364. https:\/\/doi.org\/10.1016\/j.npep.2014.01.004","journal-title":"Neuropeptides"},{"key":"1890_CR89","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.neuroscience.2018.10.004","volume":"393","author":"SD Frederiksen","year":"2018","unstructured":"Frederiksen SD, Warfvinge K, Ohlsson L, Edvinsson L (2018) Expression of Pituitary Adenylate cyclase-activating peptide, calcitonin gene-related peptide and headache targets in the trigeminal ganglia of rats and humans. Neuroscience 393:319\u2013332. https:\/\/doi.org\/10.1016\/j.neuroscience.2018.10.004","journal-title":"Neuroscience"},{"key":"1890_CR90","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/0333102410375624","volume":"31","author":"KY Chan","year":"2011","unstructured":"Chan KY, Baun M, de Vries R et al (2011) Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery. Cephalalgia 31:181\u2013189. https:\/\/doi.org\/10.1177\/0333102410375624","journal-title":"Cephalalgia"},{"key":"1890_CR91","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S0006-8993(98)00973-1","volume":"811","author":"B Fromy","year":"1998","unstructured":"Fromy B, Abraham P, Saumet J-L (1998) Non-nociceptive capsaicin-sensitive nerve terminal stimulation allows for an original vasodilatory reflex in the human skin. Brain Res 811:166\u2013168. https:\/\/doi.org\/10.1016\/S0006-8993(98)00973-1","journal-title":"Brain Res"},{"key":"1890_CR92","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1177\/0333102420957588","volume":"41","author":"F Hanci","year":"2021","unstructured":"Hanci F, Kilinc YB, Kilinc E et al (2021) Plasma levels of vasoactive neuropeptides in pediatric patients with migraine during attack and attack-free periods. Cephalalgia 41:166\u2013175. https:\/\/doi.org\/10.1177\/0333102420957588","journal-title":"Cephalalgia"},{"key":"1890_CR93","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1111\/head.14618","volume":"63","author":"YB Kilinc","year":"2023","unstructured":"Kilinc YB, Kilinc E, Danis A et al (2023) Mitochondrial metabolism related markers GDF-15, FGF\u201021, and HIF\u20101\u03b1 are elevated in pediatric migraine attacks. Headache: J Head Face Pain 63:1076\u20131086. https:\/\/doi.org\/10.1111\/head.14618","journal-title":"Headache: J Head Face Pain"},{"key":"1890_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(98)00366-2","author":"A Ebersberger","year":"1999","unstructured":"Ebersberger A, Averbeck B, Messlinger K, Reeh PW (1999) Release of substance P, calcitonin gene-related peptide and prostaglandin E2 from rat dura mater encephali following electrical and chemical stimulation in vitro. Neuroscience. https:\/\/doi.org\/10.1016\/S0306-4522(98)00366-2","journal-title":"Neuroscience"},{"key":"1890_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/0361-9230(94)00201-B","author":"A Kresse","year":"1995","unstructured":"Kresse A, Jacobowitz DM, Skofitsch G (1995) Detailed mapping of CGRP mRNA expression in the rat central nervous system: comparison with previous immunocytochemical findings. Brain Res Bull. https:\/\/doi.org\/10.1016\/0361-9230(94)00201-B","journal-title":"Brain Res Bull"},{"key":"1890_CR96","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/124.12.2490","author":"U Reuter","year":"2001","unstructured":"Reuter U, Bolay H, Jansen-Olesen I et al (2001) Delayed inflammation in rat meninges: implications for migraine pathophysiology. Brain. https:\/\/doi.org\/10.1093\/brain\/124.12.2490","journal-title":"Brain"},{"key":"1890_CR97","doi-asserted-by":"publisher","unstructured":"Strecker T, Messlinger K (2003) Neuropeptide release in the dura mater encephali in response to nitric oxide - relevance for the development of vascular headaches? Schmerz. https:\/\/doi.org\/10.1007\/s00482-003-0210-5","DOI":"10.1007\/s00482-003-0210-5"},{"key":"1890_CR98","doi-asserted-by":"publisher","unstructured":"Durham PL, Masterson CG (2013) Two mechanisms involved in trigeminal CGRP release: implications for migraine treatment. https:\/\/doi.org\/10.1111\/j.1526-4610.2012.02262.x. Headache","DOI":"10.1111\/j.1526-4610.2012.02262.x"},{"key":"1890_CR99","doi-asserted-by":"publisher","unstructured":"Charlton T, Prowse N, McFee A et al (2023) Brain-derived neurotrophic factor (BDNF) has direct anti-inflammatory effects on microglia. Front Cell Neurosci 17. https:\/\/doi.org\/10.3389\/fncel.2023.1188672","DOI":"10.3389\/fncel.2023.1188672"},{"key":"1890_CR100","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s10194-023-01572-7","volume":"24","author":"AK Musubire","year":"2023","unstructured":"Musubire AK, Cheema S, Ray JC et al (2023) Cytokines in primary headache disorders: a systematic review and meta-analysis. J Headache Pain 24:36. https:\/\/doi.org\/10.1186\/s10194-023-01572-7","journal-title":"J Headache Pain"},{"key":"1890_CR101","doi-asserted-by":"publisher","first-page":"8343","DOI":"10.3390\/ijms24098343","volume":"24","author":"G Yamanaka","year":"2023","unstructured":"Yamanaka G, Hayashi K, Morishita N et al (2023) Experimental and clinical investigation of cytokines in Migraine: a narrative review. Int J Mol Sci 24:8343. https:\/\/doi.org\/10.3390\/ijms24098343","journal-title":"Int J Mol Sci"},{"key":"1890_CR102","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1080\/00207454.2019.1681994","volume":"130","author":"Z Karaaslan","year":"2020","unstructured":"Karaaslan Z, \u00d6z\u00e7elik P, Ulukan \u00c7 et al (2020) Plasma levels of inflammatory mediators in vestibular migraine. Int J Neurosci 130:330\u2013335. https:\/\/doi.org\/10.1080\/00207454.2019.1681994","journal-title":"Int J Neurosci"},{"key":"1890_CR103","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2308-08.2008","author":"L Ulmann","year":"2008","unstructured":"Ulmann L, Hatcher JP, Hughes JP et al (2008) Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J Neurosci. https:\/\/doi.org\/10.1523\/JNEUROSCI.2308-08.2008","journal-title":"J Neurosci"},{"key":"1890_CR104","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/jphp.13233","volume":"72","author":"R Yin","year":"2020","unstructured":"Yin R, Zhao S, Qiu C (2020) Brain-derived neurotrophic factor fused with a collagen-binding domain inhibits neuroinflammation and promotes neurological recovery of traumatic brain injury mice via TrkB signalling. J Pharm Pharmacol 72:539\u2013550. https:\/\/doi.org\/10.1111\/jphp.13233","journal-title":"J Pharm Pharmacol"},{"key":"1890_CR105","doi-asserted-by":"publisher","DOI":"10.1007\/s10194-010-0233-0","author":"MTA Tanure","year":"2010","unstructured":"Tanure MTA, Gomez RS, Hurtado RCL et al (2010) Increased serum levels of brain-derived neurotropic factor during migraine attacks: a pilot study. J Headache Pain. https:\/\/doi.org\/10.1007\/s10194-010-0233-0","journal-title":"J Headache Pain"},{"key":"1890_CR106","doi-asserted-by":"publisher","DOI":"10.1242\/bio.021022","author":"J Guo","year":"2016","unstructured":"Guo J, Deng H, Bo X, Yang X (2016) Involvement of BDNF\/TrkB and ERK\/CREB axes in nitroglycerin-induced rat migraine and effects of estrogen on these signals in the migraine. Biol Open. https:\/\/doi.org\/10.1242\/bio.021022","journal-title":"Biol Open"},{"key":"1890_CR107","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0304-3959(94)00097-X","volume":"60","author":"M Fanciullacci","year":"1995","unstructured":"Fanciullacci M, Alessandri M, Figini M et al (1995) Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack. Pain 60:119\u2013123. https:\/\/doi.org\/10.1016\/0304-3959(94)00097-X","journal-title":"Pain"},{"key":"1890_CR108","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1111\/ene.15956","volume":"30","author":"A May","year":"2023","unstructured":"May A, Evers S, Goadsby PJ et al (2023) European Academy of Neurology guidelines on the treatment of cluster headache. Eur J Neurol 30:2955\u20132979. https:\/\/doi.org\/10.1111\/ene.15956","journal-title":"Eur J Neurol"},{"key":"1890_CR109","doi-asserted-by":"publisher","first-page":"100105","DOI":"10.1016\/j.ynpai.2022.100105","volume":"12","author":"P Sureda-Gibert","year":"2022","unstructured":"Sureda-Gibert P, Romero-Reyes M, Akerman S (2022) Nitroglycerin as a model of migraine: clinical and preclinical review. Neurobiol Pain 12:100105. https:\/\/doi.org\/10.1016\/j.ynpai.2022.100105","journal-title":"Neurobiol Pain"},{"key":"1890_CR110","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1080\/17460441.2023.2236545","volume":"18","author":"L Pellesi","year":"2023","unstructured":"Pellesi L (2023) The human NTG model of migraine in drug discovery and development. Expert Opin Drug Discov 18:1077\u20131085. https:\/\/doi.org\/10.1080\/17460441.2023.2236545","journal-title":"Expert Opin Drug Discov"},{"key":"1890_CR111","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1213\/01.ane.0b013e31816ba437","volume":"107","author":"RW Hurley","year":"2008","unstructured":"Hurley RW, Adams MCB (2008) Sex, gender, and Pain: an overview of a Complex Field. Anesth Analg 107:309\u2013317. https:\/\/doi.org\/10.1213\/01.ane.0b013e31816ba437","journal-title":"Anesth Analg"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-024-01890-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-024-01890-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-024-01890-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T08:02:25Z","timestamp":1729843345000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-024-01890-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":111,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1890"],"URL":"https:\/\/doi.org\/10.1186\/s10194-024-01890-4","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,25]]},"assertion":[{"value":"6 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"LDF, AA, MIA, MM, FC and MA are employees of Domp\u00e9 Farmaceutici SpA.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"184"}}